Armata Pharmaceuticals
ARMP
11 hedge funds and large institutions have $772K invested in Armata Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 6 closing their positions.
3% more capital invested
Capital invested by funds: $750K → $772K (+$22K)
21% less funds holding
Funds holding: 14 → 11 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.21M |
| 2 |
Renaissance Technologies
New York
|
+$224K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
+$72.9K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$61.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$23.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$88K |
| 2 |
FWM
Frontier Wealth Management
Kansas City,
Missouri
|
-$17K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$9K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $570K | +$1.21M | +50,066 | +2,299% |
|
|
2
Renaissance Technologies
New York
| $101K | +$224K | +9,219 | New |
|
|
ARTA
3
A.R.T. Advisors
New York
| $32K | +$72.9K | +3,004 | New |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $29K | +$61.8K | +2,549 | +2,023% |
|
|
MP
5
MSD Partners
New York
| $12K | – | – | – |
|
|
SF
6
Synovus Financial
Columbus,
Georgia
| $12K | +$21.6K | +892 | +498% |
|
|
7
UBS Group
Zurich,
Switzerland
| $11K | +$23.5K | +967 | New |
|
|
PAM
8
Panagora Asset Management
Boston,
Massachusetts
| $4K | – | – | – |
|
9
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
10
Vanguard Group
Malvern,
Pennsylvania
| – | -$88K | -1,464 | Closed |
|
|
FWM
11
Frontier Wealth Management
Kansas City,
Missouri
| – | -$17K | -286 | Closed |
|
|
12
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$11K | -183 | Closed |
|
|
13
Northern Trust
Chicago,
Illinois
| – | -$9K | -155 | Closed |
|
|
VKH
14
Virtu KCG Holdings
New York
| – | -$6K | -94 | Closed |
|
15
Bank of New York Mellon
New York
| – | -$5K | -84 | Closed |
|
ARMP Hedge Fund Activity: Q2 2017 in Review
11 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q2 2017, worth a combined $772K — up 2.9% from $750K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ARMP and 3 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 3 added.
The largest buyer was Sabby Management, adding an estimated $1.21M. The largest seller was Vanguard Group, exiting entirely with an estimated $88K sold.
- 11 institutional investors held Armata Pharmaceuticals (ARMP) as of Q2 2017, down from 14 in Q1 2017.
- Funds reported $772K of Armata Pharmaceuticals stock for Q2 2017, up 2.9% quarter-over-quarter.
- 3 funds opened new Armata Pharmaceuticals positions in Q2 2017 and 6 closed out, a net change of -3 holders.
- The largest Armata Pharmaceuticals buyer in Q2 2017 was Sabby Management, an estimated $1.21M added.
- The largest Armata Pharmaceuticals seller in Q2 2017 was Vanguard Group, an estimated $88K sold.
Based on aggregated 13F filings for Q2 2017.